Mesoblast also stated in their 23 November presentation that there was the 'potential' for first product launch in H1 CY2023 - doesn't mean it will happen but perhaps they anticipate a shorter PDUFA date than 6 months ? Who knows .... the fact is we will know when (IF) the FDA accept the BLA resubmission and issue the new PDUFA date
"Mesoblast is working towards a potential US approval for remestemcel-L and first product launch in H1 CY2023"
Happy New Year MSB'ers and GLTAH
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 707 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 7320 | 2 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |